Annual report pursuant to Section 13 and 15(d)

Note 4 - Inventories

v3.2.0.727
Note 4 - Inventories
12 Months Ended
Jun. 30, 2015
Notes to Financial Statements  
Inventory Disclosure [Text Block]
Note 4. Inventories:
 
Inventories consist of (in thousands):
 
 
 
June 30,
 
 
 
2015
 
 
20
14
 
                 
Raw materials
  $ 15,892     $ 9,852  
Finished goods
    33,685       28,995  
    $ 49,577     $ 38,847  
 
At June 30, 2015 and 2014, the Company had $24.0 million and $30.3 million, respectively, of excess protein, antibody and chemically-based inventory on hand which was not valued.